← Open Payments lookup

SOPHIA ZWIRNER: Open Payments

NPI 1982377438 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,955 in 102 payments from 15 companies in 2025. Trend: 2023 $2,230 · 2024 $2,161 · 2025 $1,955

Food & beverage: $1,880Education: $76
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.18$383
ABBVIE INC.18$292
Vanda Pharmaceuticals Inc.7$197
Neurocrine BioSciences, Inc.9$157
Teva Pharmaceuticals USA, Inc.9$148
Otsuka America Pharmaceutical, Inc.8$142
Supernus Pharmaceuticals, Inc.8$139
Janssen Pharmaceuticals, Inc4$95
Alkermes, Inc.5$89
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$77

Products named: COBENFY, VRAYLAR, FANAPT, REXULTI, INGREZZA, Qelbree, ARISTADA, CAPLYTA.

Industry payments across VA — which companies pay providers there.